New advances in artificial intelligence (AI) could streamline the process of diagnosing breast cancer. Traditional methods of mitotic counting, which assess cellular division, can be inefficient and prone to errors. With AI, this process can be standardized, reducing variability and inconsistency. However, effective implementation of these AI tools requires high-quality, diverse training data, ongoing validation, and direct feedback from pathologists. Despite the challenges, AI integration presents a promising future for breast cancer diagnostics and the broader spectrum of medical diagnostics.
![](https://healsecurity.com/wp-content/uploads/2024/07/group-ibs-threat-intelligence-and-defence-centre-equip-undergraduates-with-sophisticated.jpg)
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some